GlassScriptPhysician profile
Paul Stephen Cederna
NPI 1164520938
$1,505.96
in general payments reported to CMS, 2019-2025
10 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.41 · 2020: $152 · 2021: $18.46 · 2022: $307 · 2023: $405 · 2024: $384 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.13 | 2023 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Sientra, INC. | $304.13 | 2020-2022 | |
| Allergan, INC. | $199.24 | 2019-2022 | |
| Tela Bio, INC. | $191.28 | 2024 | Ovitex 2s |
| Axogen | $148.52 | 2025 | |
| Kerecis Limited | $145.08 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Davol INC. | $47.72 | 2024 | Phasix Mesh |
| Baxter Healthcare | $29.82 | 2020 | |
| Mentor Worldwide LLC | $18.46 | 2021 | |
| Motiva USA, LLC | $16.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Cederna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.